USD 1.05
(-1.87%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | -11.86 Thousand USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Amgen Inc. | 9.51 Billion USD | 100.0% |
AstraZeneca PLC | 5.42 Billion USD | 100.0% |
Biogen Inc. | 2.52 Billion USD | 100.0% |
Gilead Sciences, Inc. | 3.36 Billion USD | 100.0% |
Scilex Holding Company | 4.21 Million USD | 100.281% |
Scilex Holding Company | 4.21 Million USD | 100.281% |